Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (201-210 of 451) with videos related to

Pageof 46
Sort By:
Journal of Hepatology|August 27, 2013
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?Adriaan J van der Meer, Heiner Wedemeyer, Jordan J Feld, et al.
Journal of Virology|March 25, 2016
Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) ExpressionSonya A MacParland, Xue-Zhong Ma, Limin Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Spontaneous Clearance After Relapse Following Direct-Acting Antiviral Treatment for Chronic HCV InfectionHadi Kuriry, Julia Casey, Lisette Krassenburg, et al.
Atherosclerosis|April 26, 2021
Sex related differences in therapy and outcome of patients with intermittent claudication in a real-world cohortL Makowski, J Feld, J Köppe, et al.
Journal of Viral Hepatitis|February 8, 2024
Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virusRachel L Epstein, Benjamin Buzzee, Laura F White, et al.
Hepatology (Baltimore, Md.)|September 15, 2020
Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over TimeLauren Lapointe-Shaw, Hannah Chung, Laura Holder, et al.
Frontiers in Immunology|October 25, 2021
Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon SignalingDuncan Kirby, Baljyot Parmar, Sepehr Fathi, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2020
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the badMarc G Ghany, Jordan J Feld, Kyong-Mi Chang, et al.
Journal of Viral Hepatitis|November 25, 2021
The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, CanadaErin Mandel, Adriana Peci, Kirby Cronin, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.
Pageof 46

Showing results (201-210 of 451) with videos related to

Sort By:
Pageof 46
Journal of Hepatology|August 27, 2013
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?Adriaan J van der Meer, Heiner Wedemeyer, Jordan J Feld, et al.
Journal of Virology|March 25, 2016
Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) ExpressionSonya A MacParland, Xue-Zhong Ma, Limin Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2020
Spontaneous Clearance After Relapse Following Direct-Acting Antiviral Treatment for Chronic HCV InfectionHadi Kuriry, Julia Casey, Lisette Krassenburg, et al.
Atherosclerosis|April 26, 2021
Sex related differences in therapy and outcome of patients with intermittent claudication in a real-world cohortL Makowski, J Feld, J Köppe, et al.
Journal of Viral Hepatitis|February 8, 2024
Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virusRachel L Epstein, Benjamin Buzzee, Laura F White, et al.
Hepatology (Baltimore, Md.)|September 15, 2020
Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over TimeLauren Lapointe-Shaw, Hannah Chung, Laura Holder, et al.
Frontiers in Immunology|October 25, 2021
Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon SignalingDuncan Kirby, Baljyot Parmar, Sepehr Fathi, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2020
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the badMarc G Ghany, Jordan J Feld, Kyong-Mi Chang, et al.
Journal of Viral Hepatitis|November 25, 2021
The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, CanadaErin Mandel, Adriana Peci, Kirby Cronin, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.
Pageof 46